ID   ABC-5
AC   CVCL_UW52
DR   Wikidata; Q93312722
RX   PubMed=8286010;
RX   PubMed=10358721;
RX   PubMed=15999539;
CC   Population: Japanese.
CC   Doubling time: 37.9 hours (PubMed=8286010).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
RX   PubMed=8286010;
RA   Kiura, Katsuyuki
RA   Watarai, Shinobu
RA   Shibayama, Takuo
RA   Ohnoshi, Taisuke
RA   Kimura, Ikuro
RA   Yasuda, Tatsuji
RT   "Inhibitory effects of cholera toxin on in vitro growth of human lung
RT   cancer cell lines.";
RL   Anticancer Drug Des. 8:417-428(1993).
//
RX   PubMed=15999539;
RA   Matsumura, Tadashi
RA   Takigawa, Nagio
RA   Kiura, Katsuyuki
RA   Shibayama, Takuo
RA   Chikamori, Masakazu
RA   Tabata, Masahiro
RA   Ueoka, Hiroshi
RA   Tanimoto, Mitsune
RT   "Determinants of cisplatin and irinotecan activities in human lung
RT   adenocarcinoma cells: evidence of cisplatin accumulation and
RT   topoisomerase I activity.";
RL   In Vivo 19:717-721(2005).
//
RX   PubMed=10358721; DOI=10.18926/AMO/31626;
RA   Matsushita, Akio
RA   Tabata, Masahiro
RA   Ueoka, Hiroshi
RA   Kiura, Katsuyuki
RA   Shibayama, Takuo
RA   Aoe, Keisuke
RA   Kohara, Hiroyuki
RA   Harada, Mine
RT   "Establishment of a drug sensitivity panel using human lung cancer
RT   cell lines.";
RL   Acta Med. Okayama 53:67-75(1999).
//